Showing 3,441 - 3,460 results of 10,572 for search '"Tumor"', query time: 0.08s Refine Results
  1. 3441

    Nanopore-based random genomic sampling for intraoperative molecular diagnosis by Francesco E. Emiliani, Abdol Aziz Ould Ismail, Edward G. Hughes, Gregory J. Tsongalis, George J. Zanazzi, Chun-Chieh Lin

    Published 2025-01-01
    “…Abstract Background Central nervous system tumors are among the most lethal types of cancer. …”
    Get full text
    Article
  2. 3442

    Molecular Mechanism of Local Drug Delivery with Paclitaxel-Eluting Membranes in Biliary and Pancreatic Cancer: New Application for an Old Drug by Sookhee Bang, Sung Ill Jang, Su Yeon Lee, Yi-Yong Baek, Jieun Yun, Soo Jin Oh, Chang Woo Lee, Eun Ae Jo, Kun Na, Sugeun Yang, Don Haeng Lee, Dong Ki Lee

    Published 2015-01-01
    “…However, little is known about the molecular mechanisms by which paclitaxel-eluting stents attenuate tumor growth. We investigated the signal transduction pathways underlying the antiproliferative effects of a paclitaxel-eluting membrane (PEM) implanted in pancreatic/cholangiocarcinoma tumor bearing nude mice. …”
    Get full text
    Article
  3. 3443

    Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation by Chunxiao Li, Liting Xiong, Yuhan Yang, Ping Jiang, Junjie Wang, Mengyuan Li, Shuhua Wei, Suqing Tian, Yuexuan Wang, Mi Zhang, Jie Tang

    Published 2025-01-01
    “…These included subcutaneous tumor models, cell viability assays, flow cytometry, immunohistochemistry, and RNA sequencing. …”
    Get full text
    Article
  4. 3444

    Correlation between METTL3 overexpression and 18F-FDG uptake in patients with soft tissue sarcoma by Tong Wu, Jinghui Xie, Hongbo Feng, Hua Zhang, Juan Tao, Bo Chen

    Published 2025-01-01
    “…METTL3 expression in tumor and peritumoral tissues was evaluated with the Wilcoxon test. …”
    Get full text
    Article
  5. 3445

    Exercise training partly ameliorates cardiac dysfunction in mice during doxorubicin treatment of breast cancer by Tytti-Maria Uurasmaa, Pauline Bourdin, Wail Nammas, Shiva Latifi, Heidi Liljenbäck, Antti Saraste, Olli Eskola, Johan Rajander, Anne Roivainen, Helene Rundqvist, Anu Autio, Ilkka Heinonen, Katja Anttila

    Published 2025-01-01
    “…Methods Female FVB/N-mice were divided to tumor-free groups with or without voluntary wheel-running ET and those inoculated subcutaneously with mammary tumor-derived I3TC-cells with or without exercise or DOX treatment (5 mg/kg/week). …”
    Get full text
    Article
  6. 3446
  7. 3447

    DNA vaccines as promising immuno-therapeutics against cancer: a new insight by Alireza Shariati, Arya Khezrpour, Fatemeh Shariati, Hamed Afkhami, Hamed Afkhami, Hamed Afkhami, Aref Yarahmadi, Sajad Alavimanesh, Sajad Alavimanesh, Sina Kamrani, Mohammad Hossein Modarressi, Pouria Khani

    Published 2025-01-01
    “…After the T-cells have been activated, they will look for tumor antigens and destroy the tumor cells upon encountering them. …”
    Get full text
    Article
  8. 3448

    Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers by Femke A. I. Ehlers, Katie E. Blise, Courtney B. Betts, Shamilene Sivagnanam, Loes F. S. Kooreman, E. Shelley Hwang, Gerard M. J. Bos, Lotte Wieten, Lisa M. Coussens

    Published 2025-01-01
    “…Abstract Tumor-infiltrating lymphocytes are considered clinically beneficial in breast cancer, but the significance of natural killer (NK) cells is less well characterized. …”
    Get full text
    Article
  9. 3449

    Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo by Wieslawa H. Dragowska, Jagbir Singh, Mohamed Wehbe, Malathi Anantha, Katarina Edwards, Sharon M. Gorski, Marcel B. Bally, Ada W. Y. Leung

    Published 2024-12-01
    “…An efficacy study was performed in immunocompromised mice bearing established JIMT-1tumors. Autophagy markers in tumor tissue harvested after four weeks of treatment were assessed by Western blot. …”
    Get full text
    Article
  10. 3450

    Diagnostic and Prognostic Significance of Exosomes and Their Components in Patients With Cancers by Zinnat Ara Moni, Zahid Hasan, Md. Shaheen Alam, Nitai Roy, Farhadul Islam

    Published 2025-01-01
    “…On the contrary, tumor cells release more exosomes than normal cells, and these tumor‐specific exosomes can carry the genomic and proteomic signature contents of the tumor cells, which can act as tools for the diagnosis and prognosis of patients with cancers. …”
    Get full text
    Article
  11. 3451

    Clinicopathological characteristics of placental chorioangioma: A clinicopathological study of 30 cases by Yuanyin Zheng, Xiaobin Liu, Yingyu Mao, Maohua Lin

    Published 2024-12-01
    “…PCA is a rare tumor which may be misdiagnosed as a malignancy. …”
    Get full text
    Article
  12. 3452

    Unveiling the mystery of hepatic epithelioid angiomyolipoma: A unique case report with literature review by Da Teng, Yue Xu, Qingtao Meng, Qingsong Yang

    Published 2025-01-01
    “…Hepatic epithelioid angiomyolipoma is a rare mesenchymal liver tumor within the perivascular epithelioid cell tumor family, known for its uncertain malignancy and potential for aggressive behavior. …”
    Get full text
    Article
  13. 3453

    A self-assembling nanoplatform for pyroptosis and ferroptosis enhanced cancer photoimmunotherapy by Zhichao Wang, Yuqi Tang, Quan Li

    Published 2025-01-01
    “…Abstract The microenvironment of immunosuppression and low immunogenicity of tumor cells has led to unsatisfactory therapeutic effects of the currently developed nanoplatforms. …”
    Get full text
    Article
  14. 3454

    Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases by Ivana Miše, Majda Vučić

    Published 2018-01-01
    “…This study determined and compared Sdc1 expression in the tumor cells and stroma of 30 invasive lobular and 30 invasive ductal breast carcinomas (ILCs/IDCs), also in the axillary node metastases of ductal type, and correlated it with clinical and tumor parameters. …”
    Get full text
    Article
  15. 3455

    Low-grade sarcoma of the cervix: an unusual diagnosis by Maurice José González Basulto, Gustavo de Jesús Crespo Campo, Dayan Cervantes Peláez

    Published 2024-01-01
    “…Introduction: Low-grade endometrial stromal sarcoma is a tumor that represents less than one percent of all uterine malignancies. …”
    Get full text
    Article
  16. 3456

    A Rare Case of Squamous Cell Carcinoma of the Bladder Presenting as a Metastatic Right Ventricular Mass by Joanna M. Bonsall, Rhome Hughes, Mario Mosunjac, David Harrison, Habib Samady

    Published 2010-01-01
    “…Upon autopsy, the bladder was found to contain polyps of invasive squamous cell carcinoma, similar in morphology to the tumor mass in the heart. Her lungs contained multiple tumor emboli at different stages, which was likely the final cause of her death. …”
    Get full text
    Article
  17. 3457

    Th22 Cells/IL-22 Serves as a Protumor Regulator to Drive Poor Prognosis through the JAK-STAT3/MAPK/AKT Signaling Pathway in Non-Small-Cell Lung Cancer by Yinan Yao, Guangdie Yang, Guohua Lu, Jiani Ye, Luyun Cui, Zhu Zeng, Junjun Chen, Jianying Zhou

    Published 2022-01-01
    “…The interaction of immune cells and cytokines in the tumor microenvironment affects the development and prognosis of tumors with an unclear potential regulatory mechanism. …”
    Get full text
    Article
  18. 3458

    PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases by Yanmei Yang, Bin Wang

    Published 2018-01-01
    “…Recent findings have established that the distribution of BrCa metastases to the skeleton is not a random process but due to the favorable microenvironment for tumor invasion and growth. The complex interplay among BrCa cells, stromal/osteoblastic cells, and osteoclasts in the osseous microenvironment creates a bone-tumor vicious cycle (a feed-forward loop) that results in excessive bone destruction and progressive tumor growth. …”
    Get full text
    Article
  19. 3459

    Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma by Hung-Bo Wu, Shyh-An Yeh, Huei-Yung Chen

    Published 2013-01-01
    “…The tumor responded to induction chemotherapy transiently, but local progression was noted during subsequent cycles of treatment. …”
    Get full text
    Article
  20. 3460